- Gounder Gives Lowdown on Ebola, Peptides, and Colorectal Screenings
- 6 dental technology updates in May
- From clinician to leader: Building confidence, capability and leadership in dentistry
- Operationalizing AI at scale: A practical framework for enterprise-scale success
- 3 key stats on the orthodontist workforce
- Meet the COOs of 10 specialty DSOs
- Data, cross-training, and pipeline development: How health systems are rethinking OR staffing
- How top health systems are redefining the digital patient experience
- ‘The most significant change in 20 years’: Cancer centers prepare for daraxonrasib demand
- A Smooth Handoff From Decision to Dollars: Connecting the Last Mile in Healthcare Payments
- Budget-Strapped Montana Will Stress-Test Trump’s Medicaid Work Rules
- How CEOs actually use hospital rankings — and when they don’t
- What OU Health’s founding CEO learned building a new health system
- Arkansas hospital CEO to step down after 11 years for new role
- The behavioral health workforce pipeline: Where it stands and where it’s headed
- 6 major investments in youth behavioral health
- Coalition for Health AI unveils governance playbook for systems
- 66 health systems ranked by long-term debt
- UnitedHealthcare drops some prior auth requirements for cardiology, orthopedic services
- 8 No Surprises Act shake-ups physicians need to know
- The ASC independence playbook: 3 leaders’ thoughts
- Dr. Rahimah Maina opens new dental practice
- GWU offloaded its $450M physician group problem — why the industry watching
- The gastroenterologist pay gap
- Texas surgery center to double in size, add 2 ORs
- What dental leaders told us in May
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Kenyan Court Blocks Trump's Plan To Quarantine Ebola Patients
- What’s going on at the FTC? 3 notes for ASC leaders
- 8 DSOs making headlines
- The physician noncompete battle in 5 key figures
- The physician red flags that can predict a bad ASC partner
- Patient death draws renewed CMS scrutiny at HCA’s Mission Hospital
- Nearly 70% of US counties lack a GI: 13 concerning workforce stats
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- A new behavioral health profession is born
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Dentists’ pay climbed the most in these 10 states
- Mental Health Disorders Now No. 1 Cause of Disability Worldwide
- Massachusetts AG sues UnitedHealthcare over alleged Medicaid fraud
- UnitedHealthcare to nix nearly two thirds of pediatric prior auths
- Industry Voices—Patients are building a new healthcare system. The industry is finally catching up
- Weekly Rundown—Moffitt Cancer Center expands Reimagine Care's virtual oncology model; Tanner Health deploys AI workforce solution
- Study: LA Canine Outbreak Caused By Low Vaccination Rates, Crowded Boarding
- Ocrelizumab Effective In Slowing Progressive MS, Trial Shows
- Long COVID Might Be Twice As Common As Previously Thought
- In Vaccine-Skeptical California County, A Potential Playbook To Contain Measles
- Heavy Drinking Harms College Students' Brain Power, Study Finds
- After Her Bout of Amnesia, a $59,000 Billing Dispute Wouldn’t Go Away
- A Trump Stronghold Grapples With Health Risks of ICE Detention Sites
- Pharma urged to modernize patient support as young adult cancer rates rise
- Philips adds a spoonful of Disney sugar to ease kids’ MRI anxieties
- MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
- Aetna to launch ‘on demand’ virtual mental health services in 2027
- U of Connecticut dental school reappoints dean for 2nd term
- Michigan dentist charged with Medicaid fraud
- Brand-name drug prices climb after launch in US, fall abroad amid MFN push: report
- ASCO: After Takeda’s defeat, Dizal picks up baton to take on J&J in EGFR lung cancer subtype
- Acadia in the headlines: 6 things to know
- 26 behavioral health executive moves to know
- AstraZeneca gains 2nd bladder cancer nod in key expansion for Imfinzi
- Advocate Health grows Q1 revenue by 10.8% amid higher volumes, greater efficiency
- Behavioral health hospital operator to pay $32M in Medicare fraud settlement
- Bangladesh Measles Surge Kills 500+ Children; Vaccine Delays Blamed
- Care navigation startup Garner Health banks $100M series E at $2.74B valuation
- HCA bolsters workforce pipeline with healthcare professional college acquisition
- Plant-Based Diet May Cut Obesity Risk For Women In Menopause
- Pharma leaders meet with PM Takaichi in push for Japan to retain R&D edge
- Penn Medicine, K Health partner to deploy AI clinical agents
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CVS restores coverage of Eli Lilly obesity med Zepbound, adds new pill Foundayo
- CMS finalizes changes to No Surprises Act dispute resolution process
- Smartwatch App Accurately Detects Major Epileptic Seizures
- Racial Gap Exists For Asthma Inhaler Use
- New Colon Cancer Screening Guidelines Add Blood And At-Home Tests
- Fierce Pharma Asia—More China biotech hawkishness; Pfizer’s $10B Innovent deal; Astellas’ roadmap
- CVS expands partnership with Salesforce for greater call center personalization
- Nurse Convicted In Patient's Death Turns Fatal Drug Error Into Cautionary Tale
- Wearable Ultrasound Patch Monitors High-Risk Pregnancies In Real Time
- Listen to the Latest ‘KFF Health News Minute’
- In a Vaccine-Skeptical California County, a Potential Playbook To Contain Measles
- Teladoc Health inks partnership with Walmart to expand virtual care services
- PharmaEssentia taps Incyte alum Eric Vogel as it eyes Besremi expansion
- Kaléo speaks up on allergy awareness to amplify patient stories
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- NYC Health + Hospitals adds 2nd behavioral health housing site
- Mindfulness isn’t a perk anymore — it’s a workforce strategy
- With Elahere building steam, AbbVie nets FDA nod for another ImmunoGen cancer asset
- Hospitals again ask FTC, DOJ for exemption from expanded premerger notification filings
- Coalition for Health AI unveils governance playbooks for responsible AI adoption
- Amazon taps Roy Schoenberg to lead healthcare business as Neil Lindsay plans to step down
- Viridian, awaiting FDA decision, taps WuXi Bio in eye drug supply deal
- U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
- CAT on a Hot Tin Roof
- GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
- GoodRx launches subscription program for low-cost generic medications, telehealth services
- George Washington University locks deal to hand off debt-ridden physician practice to UHS
- Humana invests $83M in new Florida pharmacy distribution center
- As J&J separates from its orthopedics business, it's laying off 56 employees in New Jersey
- ASCO preview: With expectations jacked up, Akeso's ivonescimab to face scrutiny in high-stakes plenary
- An insider’s look at LillyDirect
- GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China
- Weight-Loss Program Helps Women Battling Breast Cancer
- Younger U.S. Women of Color Face Rising Breast Cancer Deaths
- High Fitness Doesn’t Raise A-fib Risk In Young Men, Study Finds
- Cheaper, Alternative Health Plans Are Having A Moment, But Critics Urge Caution
- Ultrafine Wildfire Smoke Particles May Pose Serious Health Risks
- Nurse Convicted in Patient’s Death Turns Fatal Drug Error Into a Cautionary Tale
- Montana Hurries To Adopt Trump’s Medicaid Work Rules Amid Budget Woes
- Readers Address Drugged Driving, Suicide Prevention, Worker Shortages
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Amid policy and pricing headwinds, US healthcare and life sci faces 'vast field of opportunity': survey
- Biogen investigated by Italian regulator over multiple sclerosis ‘market abuse’ claims
- FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
- Eli Lilly wins argument over Noom’s GLP-1 dosing claims
- Remarks at the Stanford Rock Center for Corporate Governance
- Smart ring maker Oura files confidentially for IPO as consumer demand propels revenue growth
- Outlook moves toward potential US nod for thrice-snubbed eye drug with FDA appeal win
- JD Power: Cost pressures worsen member experience with commercial plans
- Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
- Listen to the Latest ‘KFF Health News Minute’
- As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
- Radiopharmaceutical outfit Lantheus mulls potential $7B takeover by Curium: Bloomberg
- Everyone Has A Family Doc, But Can You Get An Appointment?
- Many U.S. College Students With Psychosis Are Not Receiving Treatment
- Antibiotics Won't Help Ease Asthma-Linked Wheezing in Kids
- Yoga Eases Insomnia And Anxiety In Cancer Survivors, Study Finds
- SK bioscience links up with Colombia to enable local production of varicella vaccine
- Dust Yields Clues to Viral Outbreaks, Study Finds
- 3 Medical Routines That Older People May Not Need
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Common Food Preservatives Linked to Major Heart Problems
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Statement on Novel Exchange-Traded Funds (ETFs)
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
The U.S. Surgeon General oversees the U.S. Public Health Service (USPHS) Commissioned Corps, over 6,000 uniformed public health officers of the HHS' Public Health Service (PHS). The United States Public Health Service Commissioned Corps is the uniformed service branch of the United States Public Health Service and one of the eight uniformed services of the United States:
https://www.newsweek.com/who-casey-means-trump-nominates-wellness-influencer-surgeon-general-2069344
Who is Casey Means? Trump Nominates Wellness Influencer as Surgeon General
By Gabe Whisnant - May 07, 2025President Donald Trump has selected Dr. Casey Means, a wellness advocate and social media influencer with close ties to Health and Human Services Secretary Robert F. Kennedy Jr., as his new nominee for U.S. surgeon general. The decision follows the withdrawal of Trump's initial pick, Dr. Janette Nesheiwat, from Senate consideration.
In a Wednesday post on social media, Trump praised Means for her health-focused background and alignment with his "Make America Healthy Again" initiative, saying she has "impeccable 'MAHA' credentials." He added, "Her academic achievements, together with her life's work, are absolutely outstanding. Dr. Casey Means has the potential to be one of the finest Surgeon Generals in United States History." Means is expected to focus on combating chronic disease and improving overall public health.
What to Know About Dr. Casey Means
Means is a wellness influencer and physician known for advocating lifestyle-based approaches to health, particularly in the areas of metabolic health, nutrition, and chronic disease prevention. A former practicing ear, nose, and throat surgeon, she co-founded the metabolic health company Levels and has gained a large following through her writings, podcasts, and social media presence focused on functional medicine and health optimization.
Her nontraditional background and emphasis on holistic wellness have made her a prominent voice in the growing movement to integrate lifestyle and nutrition into mainstream healthcare.
As surgeon general, Means would oversee the 6,000-member U.S. Public Health Service Commissioned Corps and serve as the nation's leading voice on public health, with the authority to issue advisories on major health threats.
Dr. Janette Nesheiwat Withdrawn as Trump's Surgeon General Pick
The move comes as Trump withdrew Nesheiwat's nomination amid growing scrutiny. Nesheiwat, the medical director of a New York urgent care center and a frequent Fox News contributor, had been scheduled to appear before the Senate Health, Education, Labor and Pensions Committee for her confirmation hearing Thursday. She is a vocal supporter of Trump and has a family tie to former National Security Adviser Mike Waltz, who is now Trump's pick for U.S. ambassador to the United Nations.
However, Nesheiwat faced backlash from some of Trump's far-right allies. Activist Laura Loomer criticized her credentials on social media, claiming she was "a pro-COVID vaccine nepo appointee" involved in a medical malpractice case and questioned her education.
CBS News later reported that Nesheiwat earned her medical degree from the American University of the Caribbean in St. Maarten, despite claiming it came from the University of Arkansas. The controversy mirrors another recent withdrawal—former Florida GOP Rep. Dave Weldon, who had been nominated to lead the CDC, withdrew in March after concerns about his vaccine skepticism led the White House to conclude he lacked sufficient Senate support.
Republican Senator Bill Cassidy of Louisiana singlehandedly administers American medical policy, not President Trump and HHS Secretary Kennedy:
Trump names Nicole Saphier as Surgeon General pick, withdraws Means
By Ahmed Aboulenein - April 30, 2026Summary
- Withdrawing Means deals a setback to Health Secretary Kennedy
- Trump attacks Cassidy for blocking Means' nomination
- Saphier known for breast cancer advocacy, Fox News contributions
WASHINGTON, April 30 (Reuters) - U.S. President Donald Trump named radiologist and Fox News contributor Dr. Nicole Saphier as his pick for U.S. Surgeon General on Thursday, his third nominee for the post, after withdrawing the nomination of Casey Means.
The move sets up a standoff between Trump and Republican Senator Bill Cassidy of Louisiana, whom he accused of blocking Means' nomination and called "a very disloyal person."
Means was a key ally of Health Secretary Robert F. Kennedy Jr. but lacked the votes to advance from the Senate Committee on Health, Education, Labor, and Pensions, which Cassidy chairs.
She is not a practicing doctor and is an integral part of the Make America Healthy Again movement that has undermined vaccines. Her brother Calley Means works for the White House.
Cassidy's office did not immediately respond to requests for comment on Trump's accusation or Saphier's nomination.
Means was not immediately reachable.FOX NEWS CONTRIBUTOR TAPPED FOR ROLE
As the nation's doctor, the surgeon general provides Americans with the best scientific information available on how to improve their health and reduce risk of illness and injury.
Saphier, who works at Memorial Sloan Kettering, is the author of books including "Make America Healthy Again: How Bad Behavior and Big Government Caused a Trillion Dollar Crisis."
"Nicole is a STAR physician who has spent her career guiding women facing breast cancer through their diagnosis and treatment while tirelessly advocating to increase early cancer detection and prevention," Trump wrote in a post on Truth Social.
He said in an earlier post that Means would continue to fight for the Kennedy-led Make America Healthy Again movement despite Cassidy's opposition to her nomination.
"Despite Senator Cassidy's intransigence and political games, Casey will continue to fight for MAHA on the many important Health issues facing our Country," Trump said.
Kennedy praised Means as one of his movement's "most powerful evangelist" in a post on X and accused Cassidy of "doing the dirty work for entrenched interests" by stalling her nomination. He said Means would remain a close partner.
THIRD ATTEMPT TO FILL POST
Means was Trump's second nominee for the role after he withdrew his prior pick, Janette Nesheiwat, in May. Both nominations faced opposition from far-right activists, including Laura Loomer, who is known to have Trump's ear.
Means faced pointed questioning from Democrats and some Republicans, including Cassidy, at a contentious February confirmation hearing over her views on vaccines, birth control and other areas of public health policy, as well as potential financial conflicts of interest.
She said vaccines are "a key part of any infectious disease public health strategy" but declined to directly reject a long-discredited claim linking vaccines to autism promoted by Kennedy, a longtime anti-vaccine activist.
Lisa Gilbert, co-president of watchdog Public Citizen, called the withdrawal of Means' nomination a "clear-cut victory for public health."
"Casey Means is unqualified and unfit to be Surgeon General and the withdrawal of her nomination is a win for the American public," she said in an emailed statement.
Saphier, unlike Means, holds an active medical license. She is director of breast imaging at Memorial Sloan Kettering, with a doctor of medicine degree from Ross University School of Medicine in Barbados and fellowships at the Mayo Clinic.
She shares some commonalities with the Kennedy-led movement; her book discusses preventing chronic diseases through lifestyle factors such as diet and exercise.
Senator Cassidy just came in third, in his Louisiana primary, yesterday. Big Pharma will lose a lot of clout in the U.S. Senate. Cassidy will no longer be running HHS after the first of next year:
Republican Senator Cassidy loses re-election to Trump retribution campaign
By David Morgan - May 16, 2026Summary
- Cassidy loses re-nomination after opposing Trump in impeachment trial
- Letlow and Fleming advance to June runoff for Republican Senate nomination
- Winner expected to face Democrat Jamie Davis in November general election
May 16 (Reuters) - Two-term Republican U.S. Senator Bill Cassidy lost his bid for re-election in Louisiana's primary on Saturday, as Trump-backed challenger Julia Letlow and state Treasurer John Fleming advanced to a June runoff to choose the party's nominee after a closely fought three-way battle.
Cassidy, a physician who first earned the president's ire by voting for his conviction in Trump's second Senate impeachment trial in 2021, was projected to finish in third place in a political victory for Trump's retribution campaign that recently unseated several Republican senators in Indiana who defied his push for state congressional re-districting.
The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.
He is the first elected U.S. senator to lose re-nomination since 2012.Letlow, who won Trump's Senate endorsement before she had even announced her candidacy, led Fleming 45.2% to 28.3% with 98% of votes counted, the Associated Press reported.The two candidates will now face each other in a June 27 run-off election to determine which candidate will confront Democrat Jamie Davis, who was projected to win his party's nomination, in the November general election.
The winner of the runoff is likely to fill the seat, according to independent analysts who rate Louisiana as solidly Republican.
"THANK YOU, LOUISIANA! Louisiana made it clear tonight: we are ready for strong conservative leadership that will stand with President Trump and never waver. Because of your support, your prayers, and your belief in this campaign, we are one step closer to sending that leadership to the United States Senate," Letlow said in a post on X.
Trump congratulated and praised Letlow on social media while gloating about Cassidy's loss. "His disloyalty to the man who got him elected is now a part of legend, and it’s nice to see that his political career is OVER!" Trump said in a lengthy post on Saturday night.
In his concession speech, Cassidy thanked his supporters for allowing him to represent Louisiana for 12 years."When you participate in democracy, sometimes it doesn't turn out the way you want it to. But you don't pout. You don't whine. You thank the voters for the privilege of representing the state or the country for as long as you've had that privilege," Cassidy said.
TRUMP RETRIBUTION CAMPAIGN
The Louisiana primary was the latest venue for an ongoing Trump retribution campaign that delivered primary defeats this month against at least five of seven Republican state legislators in Indiana, who opposed the president's push for a mid-decade congressional redistricting plan to protect the Republican majority in the U.S. House of Representatives.
Next week, Trump's campaign moves to Kentucky, where the president hopes to see his hand-picked primary challenger Ed Gallrein defeat Republican U.S. Representative Thomas Massie, a Trump critic and leading voice in the campaign to release government files on convicted sex offender Jeffrey Epstein, an erstwhile friend of the president.
Letlow, 45, entered Congress when her husband Luke died of a COVID infection after being elected to the House in 2020. She ran to replace him in a special election and succeeded with Trump's endorsement.
Cassidy had targeted her support for diversity, equity and inclusion initiatives when she worked for the University of Louisiana at Monroe. She responded with ads calling Cassidy and Fleming "Never Trumpers" and emphasizing her presidential endorsement.
Cassidy, a 68-year-old doctor who specialized in the treatment of liver disease and helped found a Baton Rouge clinic that serves low-income patients, served in the Louisiana Senate and the U.S. House before unseating former Democratic U.S. Senator Mary Landrieu in 2014 to become the first Republican to capture the seat since 1883.
He now chairs the Senate Health, Education, Labor and Pensions [HELP] Committee. He was re-elected in 2020 with nearly 60% of the vote.
CASSIDY VOTED TO IMPEACH TRUMP
Cassidy had a series of conflicts with Trump beginning with his role in 2021 as one of seven Republicans who supported Trump's impeachment after the January 6 attack on the U.S. Capitol by Trump supporters. He is now one of only three still in office.
Cassidy later called on Trump to drop out of the 2024 presidential race after his indictment for allegedly mishandling classified documents and declined to endorse Trump after he won the Republican nomination.
Since Trump's return to the White House, Cassidy has tried to work his way back into the president's good graces by supporting Robert F. Kennedy Jr.'s nomination for U.S. health secretary.
But Cassidy's support for Trump health policy has been short-lived, with him expressing open skepticism for Kennedy's bid to overhaul U.S. vaccine policy and joining fellow Republican Senators Susan Collins and Lisa Murkowski to slow the health secretary's agenda in Congress.
The most recent break came last month when Trump accused Cassidy of blocking the nomination of Casey Means as U.S. surgeon general, forcing the president to name radiologist and Fox News contributor Nicole Saphier as his third pick for the job.
Former Republican Senator Richard Lugar was the last elected incumbent to lose his bid for re-nomination in 2012.
The MAHA Report on Sen. Cassidy's unexpected primary collapse: “MAHA was not acting as Trump’s instrument. It was acting on its own political logic." Note that the MAHA coalition is coalescing on Sen. Roger Marshall, R-Kansas as the next Chairman of the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP):
https://www.themahareport.com/p/bill-cassidys-demise-signals-mahas
Bill Cassidy’s Demise Signals MAHA’s Rise
In Louisiana primary, Senator Bill Cassidy is defeated, proving that MAHA has come of age as a political force
By Margaret Menge - May 18, 2026The MAHA movement came into its own as a major force in American politics on Saturday, taking its first scalp by helping to defeat United States Senator Bill Cassidy in his run for re-election in Louisiana.
The moment wasn’t lost on Tony Lyons, president of MAHA PAC, which supported Cassidy’s chief rival, Louisiana Rep. Julia Letlow.
“This is a powerful indication that MAHA is a gift to the Republican Party,” Lyons told The MAHA Report on Sunday. “Candidates who accept that gift will be rewarded in the midterms. Senator Cassidy defended Big Pharma and the broken medical establishment against the health and welfare of American families. Voters across the country are joining the MAHA rebellion because they are fed up with the corruption that allowed companies to poison their children. They just won’t accept it anymore.”
MAHA PAC supported Letlow with significant financial backing and grassroots mobilizing.
“We worked very hard to ensure that Julia Letlow dominated the primary,” Lyons said. “In addition to spending $750,000 of the $1,000,000 total pledged, we encouraged thousands of MAHA influencers to support Letlow on their platforms. This group of MAHA influencers represents more than 200,000,000 followers.”
MAHA PAC also produced many effective short video ads, texts and mailers — among them, some against Cassidy and others pro-Letlow.
Cassidy is the senator who held up the confirmation of Robert F. Kennedy Jr. to serve as Secretary of Health and Human Services, forcing him to commit to giving Cassidy unprecedented say over hiring and policymaking in the agency. Cassidy also firebombed Kennedy’s pick for CDC director, Dave Weldon, and his pick for Surgeon General, Casey Means. And he held hearings at which he knew Kennedy would be attacked by former CDC employees, while initially denying the secretary an opportunity to testify in his own defense.
Cassidy also fought against Kennedy’s plan to reduce the high number of childhood vaccines. Despite Kennedy and others like Aaron Siri presenting strong evidence that many of the vaccines on the CDC schedule of recommended childhood vaccination carry serious risks of harm and even death, Cassidy, a physician, continued to insist that they are perfectly safe.
“Regarding vaccines, Mr. Kennedy has been insistent that he just wants good science and to ensure safety,” Cassidy said on the Senate floor before voting to confirm Kennedy as Secretary of HHS in February of 2025. “But on this topic, the science is good. The science is credible. Vaccines save lives. They are safe. They do not cause autism. There are multiple studies that show this. They are a crucial part of our nation’s public health response.”
In Louisiana on Saturday, Cassidy’s political career came to a sudden end as he was defeated in the Republican primary, coming in third after Rep. Julia Letlow – now a congresswoman representing Louisiana’s 5th Congressional District who was endorsed by President Trump – and John Fleming, the Louisiana state treasurer who served in the first Trump administration, at HHS, and then at the White House as an assistant to the president.
Trump endorsed Letlow even before she announced she would challenge Cassidy, writing on Truth Social in January: “I know Julia well, have seen her tested at the highest and most difficult level and she is a total winner. Should she decide to enter this race, Julia Letlow has my complete and total endorsement, run Julia, run.”
Cassidy is the first sitting U.S. Senator to be defeated in a primary since 2012, when longtime Indiana Senator Richard Lugar was defeated by state treasurer Richard Mourdock.
Letlow was the clear leader on Saturday, winning 45 percent of the vote, compared to 28 percent for Fleming and 25 percent for Cassidy – a paltry showing for a two-term United States Senator.
The two highest vote getters – Letlow and Fleming – will now face off in a June 27 runoff, with the winner facing the Democratic nominee in November.
Aaron Siri, writing on X, noted that Cassidy’s loss comes two years after another U.S. senator faced a tough re-election battle for the opposite reason. In 2021, Sen. Ron Johnson of Wisconsin broke away from the pack and held his own hearings in rooms in the Senate office buildings to give a voice to people who’d been injured by the Covid-19 vaccine. These were non-official hearings that he and his staff live-streamed and to which he invited his Senate colleagues. None came. Johnson alone among U.S. senators listened to the stories of the vaccine-injured and worked to hold the CDC and FDA accountable for failing to warn the American public of the possibility of side effects from the mRNA vaccines made by Pfizer BioNTech and Moderna. When he ran for re-election to the Senate in 2024, powerful interest groups poured millions into the race to try to bring him down. It didn’t work.
“So, Senator Ron Johnson bravely and vigorously supported medical liberty, the vaccine injured, and vaccine safety (which the media said would tank his reelection campaign) yet he won his reelection bid, while U.S. Senator Bill Cassidy did the opposite (which the media widely hailed, praised, and supported) yet he didn’t even win his primary. A lesson for all elected officials,” wrote Siri in a post on X on Sunday.
Cassidy, who was running for election to a third term, far outspent his rivals.
Federal Election Commission records show he had $8,650,205 in contributions as of April 26, and total receipts of more than $13 million. Letlow had far less – just $795,696 in contributions and $4.4 million in total receipts.
Cassidy had significant backing from the pharmaceutical industry, including contributions from political action committees connected to Pfizer, Merck, Sanofi, Abbott Laboratories, Bristol Myers Squibb, Eli Lilly, Takeda and Glaxo Smith Kline. Contributors also included the National Community Pharmacists Association PAC, the National Confectioners Association of the United States Inc. (known as CANDY PAC), the Health Industry Distributors Association PAC, and the Alliance for Pharmacy Compounding PAC.
FEC records also show a $1,000 contribution from Stanley Plotkin, known as the “godfather of vaccines” and who has become infamous after admitting under oath in a deposition with attorney Siri that dozens of infants were killed to develop vaccines and that participants in many of the vaccine safety trials he supervised were only followed for a few days or a few weeks, too short a time for any participant to be diagnosed with a chronic disease like autism or asthma.
Why else did Cassidy lose? Certainly not just because of President Trump’s endorsement of Letlow, as medical freedom activist Sayer Ji points out in a Substack post on Sunday.
“MAHA was not acting as Trump’s instrument,” he writes. “It was acting on its own political logic – the logic of a movement that watches who chairs one-sided hearings against the official they sent to Washington to reform captured health agencies, and responds accordingly.” Cassidy will continue to serve in the U.S. Senate until next January, when his Senate term expires. It’s not known, however, whether he will continue to serve as chairman of the Senate Committee on Health, Education, Labor and Pensions, or whether another chairman will be appointed.
Sen. Roger Marshall, R-Kansas, also a physician and the chairman of the new MAHA Caucus in the U.S. Senate, may be next in line for the job.
Marshall gave one of the strongest endorsements of Kennedy during his confirmation hearings in January of 2025, telling him he is “the” person for the job and that God has a divine purpose for him as Secretary of HHS.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















